Postresection irradiation for T2 N0 M0 non-small cell carcinoma: A prospective, randomized study

Annals of Thoracic Surgery

Volumn 62, Issue 3, 1996, Pages 830-834

  Lafitte, Jean J ^a   Ribet, Michel E ^a   Prévost, Bernard M ^a   Gosselin, Bernard H ^a   Copin, Marie Christine ^a   Brichet, Anne H ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0030247219     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00507-3     Document Type: Article

References (20)

1. 1. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames, IA: Iowa State University Press, 1980.
2. 2. Sørensen JB, Bradsberg JH. Prognostic factors in resected stages I and II adenocarcinoma of the lung. J Thorac Cardiovasc Surg 1990;99:218-26.
3. 3. Williams DE, Pairolero PC, Davis CS, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981;82:70-6.
4. 4. Little AG, DeMeester TR, Ferguson MK, et al. Modified stage I (T1 N0 M0, T2 N0 M0) non small cell lung cancer: treatment results, recurrence patterns and adjuvant immunotherapy. Surgery 1986;100:621-7.
5. 5. Roeslin N, Chalkidakis G, Dumont P, Witz JP. A better prognostic value from a modification of lung cancer staging. J Thorac Cardiovasc Surg 1987;94:504-9.
6. 6. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96:440-7.
7. 7. Kadri A, Dussek JE. Survival and prognosis following resection of primary non small cell bronchogenic carcinoma. Eur J Cardiothorac Surg 1991;5:132-6.
8. 8. Shields TW. Behavior of small bronchial carcinomas. Ann Thorac Surg 1990;50:691-2.
9. 9. Ichinose Y, Hara N, Ohta M, et al. Is T factor of the TNM staging system a predominant prognosis factor in pathologic stage I non-small-cell lung cancer? A multivariate prognostic factor analysis of 151 patients. J Thorac Cardiovasc Surg 1993;106:90-4.
10. 10. Feld R, Rubinstein LV, Weisenberger TH, Lung Cancer Study Group. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol 1984;2:1352-8.
11. 11. Holmes EC. Treatment of stage II lung cancer (T1 N1 and and T2 N1). Surg Clin North Am 1987;67:945-9.
12. 12. Moores DWO, McKneally MF. Treatment of stage I lung cancer (T1 N0 M0, T2 N0 M0). Surg Clin North Am 1987;67: 937-43.
13. 13. Mountain CF, Lukeman JN, Hammar SP, et al. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol 1987; 35:147-56.
14. 14. Martini N, Flehinger BJ, Nagasaki F, Hart B. Prognosis significance of N1 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 1983;86:646-53.
15. 15. Cangemi V, Volpino P, D'Andrea N, et al. Local and/or distant recurrences in T1-2/N0-1 non-small cell lung cancer. Eur J Cardiothorac Surg 1995;9:473-8.
16. 16. Mountain CF. New prognostic factors. In: Motta G, ed. Lung cancer. Frontiers in science and treatment. Genoa: Grafica, 1994:1-24.
17. 17. Marin I, Andrieu JM, Debesse B, Marsac J, Even P, Chretien J. Cancers broncho-pulmonaires non à petites cellules, de petite taille et sans adénopathies, opérés. Survie à 5 ans et siège des rechutes. Presse Méd (Paris) 1984;13:137-9.
18. 18. Yano T, Yokoyama H, Inoue T, et al. The first site of recurrence after complete resection in non-smail-cell carcinoma of the lung. J Thorac Cardiovasc Surg 1994;108:680-3.
19. 19. Mathews MJ, Kanhouwa S, Pickran J, Robinette D. Frequency of residual and metastatic tumor in patients undergoing curative surgical resection of lung cancer. Cancer Chemother Rep 1973;4:63-8.
20. 20. Vanhoutte P, Rocmans P, Smets P, et al. Post operative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 1980;6:983-6.